Total properties:
17
|
|
Patent #:
|
|
Issue Dt:
|
04/12/2016
|
Application #:
|
13861619
|
Filing Dt:
|
04/12/2013
|
Publication #:
|
|
Pub Dt:
|
03/13/2014
| | | | |
Title:
|
A Monoclonal Antibody Specifically Recognizing an Epitope for Switching to Th17 Cell
|
|
|
Patent #:
|
|
Issue Dt:
|
02/09/2016
|
Application #:
|
13861644
|
Filing Dt:
|
04/12/2013
|
Publication #:
|
|
Pub Dt:
|
03/06/2014
| | | | |
Title:
|
AN ANTIBODY SPECIFICALLY RECOGNIZING AN EPITOPE FOR SWITCHING TO TH1 CELL
|
|
|
Patent #:
|
|
Issue Dt:
|
02/09/2016
|
Application #:
|
13861675
|
Filing Dt:
|
04/12/2013
|
Publication #:
|
|
Pub Dt:
|
03/13/2014
| | | | |
Title:
|
AN ANTIBODY SPECIFICALLY RECOGNIZING AN EPITOPE FOR SWITCHING TO TH2 CELL AND A METHOD FOR CONVERTING T CELL TO TYPE 2 HELPER T CELL USING THE SAME
|
|
|
Patent #:
|
|
Issue Dt:
|
01/09/2018
|
Application #:
|
14639679
|
Filing Dt:
|
03/05/2015
|
Publication #:
|
|
Pub Dt:
|
10/26/2017
| | | | |
Title:
|
Monoclonal Antibody Which Specifically Recognizes B Cell Lymphoma and Use Thereof
|
|
|
Patent #:
|
|
Issue Dt:
|
11/12/2019
|
Application #:
|
15307820
|
Filing Dt:
|
10/29/2016
|
Publication #:
|
|
Pub Dt:
|
06/22/2017
| | | | |
Title:
|
HAR-NDS-DERIVED STEM CELLS, METHOD FOR SEPARATING SAME, AND USE THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
10/13/2020
|
Application #:
|
15691179
|
Filing Dt:
|
08/30/2017
|
Publication #:
|
|
Pub Dt:
|
03/01/2018
| | | | |
Title:
|
METHODS FOR ISOLATING AND PROLIFERATING AUTOLOGOUS CANCER ANTIGEN-SPECIFIC CD8+ T CELLS
|
|
|
Patent #:
|
|
Issue Dt:
|
12/01/2020
|
Application #:
|
15815396
|
Filing Dt:
|
11/16/2017
|
Publication #:
|
|
Pub Dt:
|
06/21/2018
| | | | |
Title:
|
NOVEL EPITOPE FOR SWITCHING TO TH17 CELL AND USE THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
03/19/2019
|
Application #:
|
15829048
|
Filing Dt:
|
12/01/2017
|
Publication #:
|
|
Pub Dt:
|
06/21/2018
| | | | |
Title:
|
MONOCLONAL ANTIBODY WHICH SPECIFICALLY RECOGNIZES B CELL LYMPHOMA AND USE THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
01/08/2019
|
Application #:
|
15863526
|
Filing Dt:
|
01/05/2018
|
Publication #:
|
|
Pub Dt:
|
09/13/2018
| | | | |
Title:
|
ANTI-HUMAN 4-1BB ANTIBODIES AND USES THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
07/06/2021
|
Application #:
|
15866061
|
Filing Dt:
|
01/09/2018
|
Publication #:
|
|
Pub Dt:
|
12/27/2018
| | | | |
Title:
|
Novel Epitope for Switching to TH2 Cell and Use Thereof
|
|
|
Patent #:
|
|
Issue Dt:
|
02/25/2020
|
Application #:
|
15936209
|
Filing Dt:
|
03/26/2018
|
Publication #:
|
|
Pub Dt:
|
08/02/2018
| | | | |
Title:
|
METHODS FOR ISOLATING AND PROLIFERATING AUTOLOGOUS CANCER ANTIGEN-SPECIFIC CD8+ T CELLS
|
|
|
Patent #:
|
|
Issue Dt:
|
02/16/2021
|
Application #:
|
16191381
|
Filing Dt:
|
11/14/2018
|
Publication #:
|
|
Pub Dt:
|
03/07/2019
| | | | |
Title:
|
ANTI-HUMAN 4-1BB ANTIBODIES AND USES THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
02/16/2021
|
Application #:
|
16239398
|
Filing Dt:
|
01/03/2019
|
Publication #:
|
|
Pub Dt:
|
10/31/2019
| | | | |
Title:
|
IFN-Gamma-Inducible Regulatory T Cell Convertible Anti-Cancer (IRTCA) Antibody and Uses Thereof
|
|
|
Patent #:
|
|
Issue Dt:
|
04/21/2020
|
Application #:
|
16255690
|
Filing Dt:
|
01/23/2019
|
Publication #:
|
|
Pub Dt:
|
08/01/2019
| | | | |
Title:
|
IFN-Gamma-Inducible Regulatory T Cell Convertible Anti-Cancer (IRTCA) Antibody and Uses Thereof
|
|
|
Patent #:
|
|
Issue Dt:
|
05/25/2021
|
Application #:
|
16715462
|
Filing Dt:
|
12/16/2019
|
Publication #:
|
|
Pub Dt:
|
07/30/2020
| | | | |
Title:
|
CHIMERIC ANTIGEN RECEPTOR THAT BINDS HLA-DR AND CAR-T CELL
|
|
|
Patent #:
|
|
Issue Dt:
|
09/15/2020
|
Application #:
|
16790299
|
Filing Dt:
|
02/13/2020
|
Publication #:
|
|
Pub Dt:
|
06/04/2020
| | | | |
Title:
|
ANTI-HUMAN 4-1BB ANTIBODIES AND USES THEREOF
|
|
|
Patent #:
|
|
Issue Dt:
|
02/23/2021
|
Application #:
|
16838887
|
Filing Dt:
|
04/02/2020
|
Publication #:
|
|
Pub Dt:
|
09/17/2020
| | | | |
Title:
|
ANTI-HUMAN VSIG4 ANTIBODIES AND USES THEREOF
|
|